Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and financial resilience in 2026.

The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...

As the new year begins, gyms are crowded, dietitians’ schedules are packed and dental chairs are filled — signs that Americans are embracing their New Year’s resolutions to focus on health. Alongside ...

In the latest legal development in the ongoing 340B contract pharmacy litigation, the United States Court of Appeals for the District of Columbia Circuit ruled earlier this week that the 340B Drug ...

What does it mean to be a patient? For some, it means access to the best doctors and hospitals. For others, it means a courageous battle against a chronic, and perhaps incurable disease. And for many, ...

Recent polling shows most voters believe lowering out-of-pocket costs is the top health care priority for the country. For low-income and uninsured patients, the impact of rising out-of-pocket costs ...

During a session at AMCP Nexus, panelists provided a historical overview on the 340B drug discount program, highlighting the intentions of the plan and the research gaps leading to misconceptions ...

COA warns First Circuit for-profit PBM-affiliated contract pharmacies have hijacked the 340B program WASHINGTON, DC, UNITED STATES, November 24, 2025 /EINPresswire ...

The pharmaceutical industry’s relentless, astronomically expensive campaign to smear the 340B Drug Pricing Program — one of the world’s most important humanitarian programs — knows no bounds. Our ...

The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...